The impact of socioeconomic factors on the efficacy of bevacizumab for macular edema secondary to retinal vein occlusion

被引：0
|
作者：
Sanjiv, Nayan [1 ]
Prasad, Minali [2 ]
Goodman, Deniz [2 ]
Osathanugrah, Pawarissara [1 ]
Chen, Xuejing [1 ]
Ness, Steven [1 ]
Siegel, Nicole [1 ]
Subramanian, Manju L. [1 ]
机构：
[1] Boston Med Ctr, Ophthalmol, Boston, MA USA
[2] Boston Univ, Chobanian & Avedisian Sch Med, Ophthalmol, Boston, MA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2024年 / 65卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1728
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion
    Ach, Thomas
    Hoeh, Alexandra E.
    Schaal, Karen B.
    Scheuerle, Alexander F.
    Dithmar, Stefan
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (02) : 155 - 159
  • [32] Efficacy of conbercept after switching from bevacizumab/ranibizumab in eyes of macular edema secondary to central retinal vein occlusion
    Zhao, Tong
    Chen, You
    Zhang, Hong-Song
    Chen, Yi
    Wang, Zhi-Jun
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2022, 15 (04) : 609 - 614
  • [33] Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion
    Kartasasmita, Arief S.
    Takarai, Siska
    Switania, Astriviani
    Enus, Sutarya
    CLINICAL OPHTHALMOLOGY, 2016, 10 : 2135 - 2140
  • [34] Efficacy of conbercept after switching from bevacizumab/ranibizumab in eyes of macular edema secondary to central retinal vein occlusion
    Tong Zhao
    You Chen
    Hong-Song Zhang
    Yi Chen
    Zhi-Jun Wang
    International Journal of Ophthalmology, 2022, (04) : 609 - 614
  • [35] Long Term Efficacy of Intravitreal Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions
    He, Xining
    Elia, Maxwell
    Hsieh, Eric
    Adelman, Ron A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [36] Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion
    Ozgonul, Cem
    Dedania, Vaidehi S.
    Besirli, Cagri G.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 34 (04) : 340 - 345
  • [37] The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
    Gokce, Gokcen
    Sobaci, Gungor
    Durukan, Ali Hakan
    Erdurman, Fazil Cuneyt
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 355 - 362
  • [38] Intravitreal bevacizumab combined with grid photocoagulation in recurrent macular edema secondary to retinal vein occlusion
    Farese, Elvira
    Cennamo, Gilda
    Velotti, Nunzio
    Traversi, Claudio
    Rinaldi, Michele
    De Crecchio, Giuseppe
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2014, 24 (05) : 761 - 770
  • [39] Aflibercept versus bevacizumab and/or ranibizumab for recurrent macular edema secondary to central retinal vein occlusion
    Dedania, Vaidehi
    Ozgonul, Cem
    Besirli, Cagri G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [40] Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review and Meta-Analysis
    Lu, Yi
    Su, Li
    Xu, Xun
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 29 (08) : 702 - 708
12345